Viewing Study NCT06549335


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2025-12-31 @ 5:55 AM
Study NCT ID: NCT06549335
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-15
First Post: 2024-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
Sponsor:
Organization: